NCT00924131

Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial

Completed Last updated 2 July 2017

What this trial tests

trial in Hodgkin's Disease in 157 participants. Completed in 26 May 2010.

Timeline

17 April 2009

26 May 2010

Quick facts

Lead sponsor	National Cancer Institute (NCI)
Status	Completed
Study type	OBSERVATIONAL
Enrollment	157
Start date	17 April 2009
Estimated completion	26 May 2010
Sites	1 location across United States

Conditions studied

• Hodgkin's Disease — all drugs for Hodgkin's Disease →
• Lymphoma — all drugs for Lymphoma →

Sponsor

National Cancer Institute (NCI)

Who can join

Adults 18 to 100, any sex, with Hodgkin's Disease or Lymphoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background:

* Researchers are greatly interested in knowing more about the long-term effects of various treatments for cancers such as Hodgkin's disease, particularly from those who have lived 20 to 30 years after treatment.
* Patients who were treated at the National Institutes of Health (NIH) may have undergone different treatments for which more long-term information is needed.

Objectives:

* To examine the body systems of long-term survivors of Hodgkin's disease to see if there are any long- term consequences of treatment for Hodgkin's disease.
* To learn more about the long-term effects of cancer treatments.

Eligibility:

* Survivors of Hodgkin's disease who were previously treated at the NIH.
* Participants must be at least 18 years of age.

Design:

* Participants will need to sign consent forms to allow researchers to obtain documentation of medical history, including prior treatment for Hodgkin's disease and prior NIH treatment, including protocol number, where applicable:
* Pertinent medical records, pathology reports, and radiographic imaging studies will be reviewed.
* Primary care physician's name, address, and other contact information are also required.
* Evaluations during the assessment period:
* Complete physical examination.
* Laboratory studies of blood, urine, and stool samples.
* Radiologic evaluations, including computerized tomography (CT) and magnetic resonance imaging (MRI) scans for all participants and mammograms for females.
* Cardiac evaluation, vascular studies, and pulmonary studies to measure heart and lung function, and digestive tests to measure stomach and intestinal function.
* Neurocognitive testing to measure brain function.
* Optional skin biopsy.
* Participants will be asked to complete questionnaires assessing current quality of life and daily living skills.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.